Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Priority review status assigned to Rapamune immunosuppressive therapy

Feb. 3, 1999

New herpes vaccine from Cel-Sci proves effective in protecting mice

Feb. 1, 1999

OraVax, Peptide Therapeutics and Pasteur Merieux Connaught announce agreements

Feb. 1, 1999

Antex Biologics successfully completes phase I study of Helicobacter vaccine

Jan. 29, 1999

Yoshitomi's new immunosuppressive agents for arthritis, autoimmune diseases and transplant rejection

Jan. 27, 1999

Another significant market introduction for basiliximab

Jan. 25, 1999

Glaxo Wellcome and PowderJect expand DNA vaccine collaboration

Jan. 25, 1999

Alpha-Beta Technology discontinues phase III trial of Betafectin

Jan. 25, 1999

Cel-Sci and University of Maryland receive award for TB vaccine development

Jan. 22, 1999

Terprenin: novel immunosuppressant and antiallergic substance under evaluation at Shionogi

Jan. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.